ETFS Holding Antares Pharma, Inc.

 
Stock Quotes for Antares Pharma, Inc. top ^
  • Industry: Medical Instruments & Supplies
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for atrs investment picks
  • Industry: Medical Instruments & Supplies
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for atrs investment picks

 
News Articles for Antares Pharma, Inc. top ^
Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the third quarter ended September 30, 2014.
Sign-up for Antares Pharma Reports Third Quarter 2014 Operating and Financial Results investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the last patient has been enrolled in a double-blind, multiple-dose, phase 3 study to evaluate the efficacy and safety of QuickShot ® Testosterone (QS T) administered subcutaneously once each week to testosterone-deficient adult males.
Sign-up for Antares Pharma Announces Last Patient Enrolled in Phase 3 QuickShot® Study Evaluating Testosterone-Deficient Adult Males investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2014 financial results before the market opens on Thursday, November 6, 2014 and host a conference call at 8:30 a.m. ET (Eastern Time) to discuss the results.
Sign-up for Antares Pharma to Host Third Quarter 2014 Operating and Financial Results Conference Call investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of James E.
Sign-up for Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.
Sign-up for Antares Pharma to Present at the 26th Annual Piper Jaffray Healthcare Conference investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.
Sign-up for Antares Pharma to Present at the 25th Annual Oppenheimer Healthcare Conference investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P.
Sign-up for Antares Pharma to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that it has received written recommendations from the U.S. Food and Drug Administration (FDA) related to its clinical development program for QuickShot ® Testosterone (QS T). The recommendations received were in response to various clinical, CMC (Chemistry, Manufacturing and Controls) and user study submissions made by the Company through November 2014.
Sign-up for Antares Pharma Announces Update to QuickShot® Testosterone Program investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
ETFS Holding Antares Pharma, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding ANSYS, Inc.  |  Next: ETFS Holding Antofagasta PLC